Modern staging of small cell lung cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 11, Issue 1, 2013, Pages 99-104

  Kalemkerian, Gregory P ^a,c   Gadgeel, Shirish M ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BONE MARROW BIOPSY; BONE SCINTISCANNING; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER STAGING SYSTEM; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; RADIATION FIELD; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; VETERANS ADMINISTRATION LUNG STUDY GROUP 2 STAGE;

EID: 84874589687     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0012     Document Type: Review

References (30)

1. Navada S, Lai P, Schwartz AG, Kalemkerian GP. Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results database [abstract]. J Clin Oncol 2006;24(18S-Part I):Abstract 384s.
2. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep (Part 3) 1973;4:31-42.
3. Stahel RA, Ginsberg R, Havemann K, et al. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989;5:119-126.
4. Micke P, Faldum A, Metz T, et al. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease? Lung Cancer 2002;37:271-276.
5. American Joint Committee on Cancer. AJCC Cancer Staging Handbook, 7th Edition. Springer, NY: New York; 2010:299-323.
6. Shepherd FA, Crowley J, Van Houtte P, et al. The IASLC Lung Cancer Staging Project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007;2:1067-1077.
7. Vallieres E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:1049-1059.
8. Ou SH, Zell JA. The applicability of the proposed IASLC staging revisions to small cell lung cancer with comparison to the current UICC 6th TNM edition. J Thorac Oncol 2009;4:300-310.
9. Hochstenbag MMH, Twijinstra A, Wilmink JT, et al. Asymptomatic brain metastases in small cell lung cancer: MR-imaging is useful at initial diagnosis. J Neurooncol 2000;48:243-248.
10. Seute T, Leffers P, Wilmink, JT, et al. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol 2006;24:2079-2083.
11. Campling B, Quirt I, DeBoer G, et al. Is bone marrow examination in small-cell lung cancer really necessary? Ann Int Med 1986;105:508-512.
12. Tritz DB, Doll DC, Ringenberg QS, et al. Bone marrow involvement in small cell lung cancer: clinical significance and correlation with routine laboratory variables. Cancer 1989;63:763-766.
13. Levitan N, Byrne RE, Bromer RH, et al. The value of the bone scan and bone marrow biopsy in staging small cell lung cancer. Cancer 1985;56:652-654.
14. Kalemkerian GP, Akerley W, Bogner P, et al. NCCN Clinical Practice Guidelines in Oncology: Small Cell Lung Cancer. Version 2, 2012. Available at: NCCN.org. Accessed November 20, 2012.
15. Hauber HP, Bohuslavizki KH, Lund CH, et al. Positron emission tomography in the staging of small-cell lung cancer: a preliminary study. Chest 2001;119:950-954.
16. Schumacher T, Brink I, Mix M, et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur J Nucl Med 2001;28:483-488.
17. Shen YY, Shiau YC, Wang JJ, et al. Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer. Anticancer Res 2002;22:1257-1264.
18. Chin R, McCain TW, Miller AA, et al. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study. Lung Cancer 2002;37:1-6.
19. Kamel EM, Zwahlen D, Wyss MT, et al. Whole-body 18F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003;44:1911-1917.
20. Bradley JD, Dehdashti F, Mintun MA, et al. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 2004;22:3248-3254.
21. 18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004;31:1614-1620.
22. Blum R, MacManus MP, Rischin D, et al. Impact of positron emission tomography on the management of patients with small cell lung cancer: preliminary experience. Am J Clin Oncol 2004;27:164-171.
23. Kut V, Spies W, Spies S, et al. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography. Am J Clin Oncol 2007;30:45-50.
24. Fischer BM, Mortensen J, Langer SW, et al. A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol 2007;18:338-345.
25. Niho S, Fujii H, Murakami K, et al. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET scan in apparent limited-disease small-cell lung cacner. Lung Cancer 2007;57:328-333.
26. Vinjamuri M, Craig M, Campbell-Fontaine A, et al. Can positron emission tomography be used as a staging tool for small-cell lung cancer? Clin Lung Cancer 2008;9:30-34.
27. Azad A, Chionh F, Scott AM, et al. High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer. Mol Imaging Biol 2010;12:443-451.
28. Arslan N, Tuncel M, Kuzhan O, et al. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer. Ann Nucl Med 2011;25:406-413.
29. 18FDG-PET based radiation planning of the mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study. Radiother Oncol 2008;87:49-54.
30. van Loon J, De Ruysscher D, Wanders R, et al. Selective nodal irradiation on basis of 18FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2010;77:329-336.